Durect
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Durect sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Durect: 10 sponsored US clinical trials, none currently recruiting.
Durect sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 2 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Abdominal Surgery, with 1 trials.
Top-decile sponsor footprint
Durect ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
8 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
10 total, page 1 of 1
A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment
NCT04563026
DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury
NCT04447404
Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis
NCT03837743
A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis
NCT03432260
A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)
NCT03394781
Trial of Extended Release Bupivacaine for Pain Relief After Surgery
NCT02574520
Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain
NCT01096966
Bupivacaine Effectiveness and Safety in SABER® Trial
NCT01052012
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
NCT00485225
Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia
NCT00478179
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 8 |
| Phase 3 | 2 |
Therapeutic Areas
How the Durect early-phase archive is shaped
10 indexed studies, none listed as recruiting (0% open); 8 completed (80%).
Phase mix: 2 late (III/IV) vs 8 early (I/II) (early-phase heavy).
Top condition: Abdominal Surgery (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Durect: archived-pipeline peers nationwide
Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Durect sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 archived trials
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Durect page
10 registered trials is a research-attention snapshot, not an endorsement of Durect or any single study.
- None of Durect's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Abdominal Surgery is the condition Durect studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Abdominal Surgery trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Durect pipeline card: 10 registered trials from official public datasets.Report a data error.